US42226A1079
US42226A1079
HealthEquity, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q3 '26 31.07.2026 | Q2 '26 30.04.2026 | Q1 '26 31.01.2026 | Q4 '25 31.10.2025 |
|---|---|---|---|---|---|
Market & Enterprise Value | |||||
Market Cap | 7.66B EUR | 8.34B EUR | 6.88B EUR | 7.28B EUR | 8.1B EUR |
Enterprise Value | 8.41B EUR | 9.06B EUR | 7.6B EUR | 7.97B EUR | 8.82B EUR |
Valuation Multiples | |||||
Trailing P/E | 33.43x | 35.27x | 29.84x | 45.15x | 72.59x |
Forward P/E | 16.84x | -- | -- | -- | -- |
Price to Sales | 5.62x | 6.12x | 5.15x | 7.41x | 12.5x |
Price to Book | 3.86x | 4.19x | 3.36x | 3.46x | 3.79x |
EV/Revenue | 6.18x | 6.65x | 5.69x | 8.11x | 13.61x |
EV/EBITDA | 16.38x | 17.3x | 14.83x | 21.62x | 34.68x |
Price to FCF (P/FCF) | 19.27x | 19.1x | 15.61x | 20.24x | 32.15x |
EV/FCF | 21.16x | 20.74x | 17.24x | 22.14x | 35x |
FCF Yield | 5.19% | 5.23% | 6.41% | 4.94% | 3.11% |